Open Access Article
This Open Access Article is licensed under a
Creative Commons Attribution 3.0 Unported Licence

Blue-green emissive cationic iridium(III) complexes using partially saturated strongly-donating guanidyl-pyridine/-pyrazine ancillary ligands

Kamrul Hasan a, Amlan K. Pal a, Thomas Auvray a, Eli Zysman-Colman *b and Garry S. Hanan *a
aDépartement de Chimie, Université de Montréal, 2900 Edouard-Montpetit, Montréal, Québec H3T-1J4, Canada. E-mail: garry.hanan@umontreal.ca; Fax: +1 514 343-2468; Tel: +1 514 343-7056
bOrganic Semiconductor Centre, EaStCHEM School of Chemistry, University of St Andrews, St Andrews, Fife KY16 9ST, UK. E-mail: eli.zysman-colman@st-andrews.ac.uk; Web: http://www.zysman-colman.com Fax: +44 (0)1334 463808; Tel: +44 (0)1334 463826

Received 17th May 2015 , Accepted 31st July 2015

First published on 31st July 2015


Abstract

A new class of cationic iridium(III) complexes of the form [(CN)2Ir(NN)][PF6] is reported, where CN = cyclometallating 2-phenylpyridinato, ppy, or 2-(2,4-difluorophenyl)-5′-methylpyridinato, dFMeppy, and NN = guanidyl-pyridine, gpy, or -pyrazine, gpz, as the ancillary ligand. A large blue-shift in the emission coupled with a 7-to-9 fold enhancement in photoluminescence quantum yield and microsecond emission lifetimes were observed for the complexes containing the partially saturated gpy ligand as compared to the benchmark complex [(ppy)2Ir(bpy)][PF6], C1, where bpy is 2,2′-bipyridine.


Cationic iridium(III) complexes are the subject of tremendous recent interest due to their use as photophysically active materials in a wide assortment of applications, e.g., lighting devices,1 solar energy harvesters,2 in sensing or bioimaging3 and photosensitizers for hydrogen production from water.4 Generally, the photophysical properties of these complexes can be finely tuned through concomitant modification of the cyclometallating and ancillary ligands. In particular, replacing the 2,2′-bipyridine (bpy) in the archetypal [(ppy)2Ir(bpy)][PF6], C1, with other bidentate heterocyclic ligands has proven to be very effective in modulating the emission energy (ppy = 2-phenylpyridinato). For instance, complexes bearing phenanthroline-,5a imidazole-,5b 1,2,3-triazole-,5c tetrazole-5d and pyrazole5e-based ancillary ligands have all been investigated.5f To the best of our knowledge partially saturated, strongly-donating neutral N,N′-bidentate heterocycles have not been explored as ancillary ligands with iridium(III) complexes. Very recently multi-dentate guanidyl-based ligands and their ruthenium complexes have been studied by the Hanan group.6 The incorporation of strongly donating H-hpp (where H-hpp = 1,3,4,6,7,8-hexahydro-2H-pyrimido[1,2-a]pyrimidine or commonly known as guanidine in this work) moieties into N-heterocycles by means of C–N bond-forming reactions gave rise to electron-rich bidentate or tridentate chelates.7 These ligands conferred large red-shifts of between 120–270 nm of the lowest triplet energy metal-to-ligand charge-transfer, 3MLCT, emission band of their Ru(II)-complexes as compared to [Ru(bpy)3]2+ and [Ru(tpy)2]2+ (tpy = 2,2′:6′,2′′-terpyridine).6 Herein, we present the first three examples of cationic iridium(III) complexes that incorporate neutral bidentate 2-guanidylpyridine, gpy, and 2-guanidylpyrazine, gpz, as the ancillary ligand (Scheme 1) and contrast their photophysical properties to those of C1. The observed optoelectronic properties align with the density functional theory (DFT) and time-dependant DFT (TD-DFT) studies (vide infra).
image file: c5cc04069h-s1.tif
Scheme 1 Syntheses of 1–3 (a) i. 2.1 equiv. gpy in DCM/MeOH (1[thin space (1/6-em)]:[thin space (1/6-em)]1), 50 °C, 19 h; ii. NH4PF6 (aq). (b) i. 2.1 equiv. gpz in DCM/MeOH (1[thin space (1/6-em)]:[thin space (1/6-em)]1), 50 °C,19 h; ii. NH4PF6 (aq).

The gpy and gpz ligands were synthesized in high yields (95% and 82%) according to the literature.6a These ligands were used to cleave [(ppy)2Ir(μ-Cl)]2 and [(dFMeppy)2Ir(μ-Cl)]2 (dFMeppy = 2-(2,4-difluorophenyl)-5-methylpyridinato) and complexes 1–3 were obtained in high yield (80–90%) following an anion metathesis with aq. NH4PF6 (Scheme 1). They were fully characterized by 1H-, 13C-, 19F-NMR spectroscopy, melting point and HR-MS analyses (Fig. S1–S11 in ESI). Resonances in the 1H NMR spectra of 1–3 corresponding to the saturated aliphatic backbone of the ancillary ligand were observed between 1 to 4 ppm as found in other complexes with saturated ligands.8 The splitting of the methylene protons suggest that they are diastereotopic as also observed for analogous Ru complexes.6b–e

Crystals of 3 suitable for X-ray structural determination were grown by slow evaporation from a mixture of DCM and diisopropylether (1[thin space (1/6-em)]:[thin space (1/6-em)]1, v/v) (Fig. 1). Selected crystallographic parameters are tabulated in Table S1 (ESI). Selected bond distances and angles are in Table S2 (ESI). The Ir(III)-ion is coordinatively saturated and in a distorted octahedral geometry. The CN carbon atoms are found to be mutually cis disposed, similar to the solid-state structure of C1 (CCDC 745138).9 The average Ir–Cppy (2.005(10) Å) and Ir–Nppy (2.054(8) Å) bond lengths are similar to those in C1 [Ir–Cppy (2.013(3) Å); Ir–Nppy (2.045(3) Å)]. The NNN–Ir–NNN bite angle (83.8(3)°) of the gpz is wider than when bpy is the ancillary ligand in C1, 76.2(1)° due to formation of a six-membered chelate ring present in 3.


image file: c5cc04069h-f1.tif
Fig. 1 ORTEP view of complex 3. Hydrogen atoms, an anion and a solvated dichloromethane molecule have been omitted for clarity. Ellipsoids correspond to a 50% probability level.

image file: c5cc04069h-f2.tif
Fig. 2 Calculated frontier MO energies of 1–3, obtained from TD-DFT [(rb3lyp/LanL2DZ(f) for Ir(III)) and (6-31g** for C,H,N,(F))] with CPCM(CH3CN) and 0.5 eV threshold of degeneracy. Kohn–Sham MOs of 1, 2 and 3 are also shown (contours isovalue: 0.03).

The UV-visible absorption spectra of 1–3 are shown in Fig. S12 (ESI) and calculated molar absorptivities are reported in Table S3 (ESI). The absorption profiles are similar to other heteroleptic cationic iridium(III) complexes reported in the literature.10 TD-DFT studies assign the bands below 300 nm as predominantly ligand-centred spin allowed π–π* transitions from both ligands with minor contributions from 1MLCT and 1LLCT (1MLCT = singlet metal-to-ligand charge transfer and 1LLCT = singlet ligand-to-ligand charge transfer).11 The absorption bands in the 300–450 nm region are mainly mixed spin-allowed CT transitions (for relative contributions see Tables S5–S7, ESI) with non-negligible contribution from ligand-centred transitions. The lowest energy absorption bands in 1–3 are slightly red-shifted by 23–41 nm compared to C1 (420 nm) in an analogous manner to the trend observed with [(bpy)2Ru(gpy/gpz)]+2vs. reference [Ru(bpy)3]+2.6a The red-shift in the absorption spectra of 1–3 is due to a destabilization of the metal/CN-localized HOMO as a result of increased electron density on the iridium conferred by the electron-donating gpy ligand (HOMO = highest occupied molecular orbital, Tables S8–S10 and Fig. S15, ESI). The decreasing optical gap (inset figure of Fig. S12, ESI) from 2 to 1 to 3 aligns with the computed HOMO–LUMO (LUMO = lowest unoccupied molecular orbital) energy gap (ΔE of 2 = 3.91 eV; ΔE of 1 = 3.72 eV; ΔE of 3 = 3.31 eV) (Fig. 2 and Table S3, ESI).

The electrochemical behaviour of 1–3 was monitored by cyclic voltammetry (CV) and the CV traces in deaerated MeCN containing 0.1 M n-Bu4NPF6 as the supporting electrolyte and using Fc/Fc+ as an internal standard at 298 K are shown in Fig. S13 and S14 (ESI). The detailed CV data vs. SCE (Fc/Fc+ = 0.38 V in MeCN)12 are summarized in Table S4 (ESI) while only first redox potentials are listed in Table 1. In the anodic scan, all of the complexes showed three successive oxidation waves, the first quasi-reversible and the other two irreversible. The first oxidation wave of 1–3 falls between 0.99 to 1.21 V (Fig. S14, ESI) and is assigned to the IrIII/IV redox couple with contributions from the CN ligands.5f These oxidation potentials are cathodically shifted to a significant extent compared to other heteroleptic iridium(III) cationic complexes bearing similar CN ligands, (C1: E1/2ox = 1.27 V vs. SCE; [(dFMeppy)2Ir(bpy)][PF6], C2: E1/2ox = 1.55 V vs. SCE). Indeed, DFT calculations show that the HOMOs of 1–3 are constituted almost equally with iridium and the CN ligands with a progressive increase in the calculated energy of the HOMO of 2 (EHOMO = −5.66 eV) to 3 (EHOMO = −5.43 eV) to 1 (EHOMO = −5.32 eV), which is in excellent agreement with experiment. The first oxidation potential of 2 (E1/2ox = 1.21 V) is more positive compared to that of 1 (E1/2ox = 0.99 V) due to the electron withdrawing fluorine atoms on the CN ligands, which increase the stability of HOMOs. The E1/2ox of 3 is slightly more positive (1.04 V) compared to that of 1, although both contain the same cyclometallating ppy ligand. This is due to modulating influence of the less electron-donating gpz ligand. Overall, the trends observed in the electrochemistry are entirely consistent with those in the electronic spectroscopy.

Table 1 Optoelectronic properties of 1–3 in degassed MeCNa
  λ em/nm Φ PL/% τ e /μs k r/105 s−1 k nr/105 s−1 E 1[thin space (1/6-em)]ox1/2/V (ΔEp, mV) E 1[thin space (1/6-em)]red1/2 /V (ΔEp, mV)
a Φ PL was measured at 298 K using quinine sulfate (ΦPL = 54%, in 0.5 N H2SO4) as in ref. 16. kr = Φ/τ and knr = (1 − Φ)/τ. CV values are in V vs. SCE.9 ΔEp = |EpaEpc|, where Epa = anodic peak potential and Epc = cathodic peak potential; E1/2 = (Epa + Epc)/2 and result from one-electron processes. A non-aqueous Ag/Ag+ electrode (silver wire in a solution of 0.1 M AgNO3 in MeCN) was used as the pseudoreference electrode; a glassy-carbon electrode was used for the working electrode and a Pt electrode was used as the counter electrode.
1 503 60 2.1 2.9 1.9 0.99 (88) −2.13
2 470, 498 62 2.6 2.3 1.4 1.21 (72) −2.12
3 640 0.2 0.02 1.0 499 1.04 (92) −1.60 (95)


Upon scanning to negative potential, 1 and 2 show three successive one-electron irreversible reduction-waves whereas complex 3 shows a first quasi-reversible one-electron reduction followed by two irreversible one-electron reduction events (Fig. S13 and Table S4, ESI). The first of the reduction waves falls between −2.12 to −1.60 V, which are more cathodically shifted compared to benchmark complexes C1 and C2 (C1: E1/2red = −1.38 V; C2: E1/2red = −1.34 V). The more negative reduction potentials in 1–3 are the result of the strongly electron-donating guanidyl moiety. Similar effects were previously observed for more electron rich ancillary ligands (NN). For instance, the first reduction waves of [(ppy)2Ir(btl)]PF613a and [(ppy)2Ir(4-pytl)]PF613b were found, respectively, at −1.99 and −2.25 V vs. SCE (btl = 1,1′-benzyl-4,4′-bi-1H-1,2,3-triazolyl and 4-pytl = 4-methyl-3-(pyridin-2-yl)-1,2,4-triazole). In the case of complexes [(dFppy)2Ir(3-pytl)]14a and [(Fphtl)2Ir(3-pytlph)]PF614b (where 3-pytl = 2-(1,2,3-triazol-5-yl)pyridine, Fphtl = 1-benzyl-4-(4-fluorophenyl)-1H-1,2,3-triazole and 3-pytlph = 2-(1-phenyl-1,2,3-triazol-4-yl)pyridine, respectively) the reduction waves were observed at −2.39 and −1.76 V vs. SCE. In our case, the first reduction waves of 1 and 2 are almost identical at −2.13 and −2.12 V, respectively, as indeed both complexes have the same gpy ancillary ligand. On the other hand, the first reduction wave of 3 is at −1.60 V with gpz as the ancillary ligand. The σ-donating effect is mitigated in 3 due to the presence of the extra inductively electron-withdrawing nitrogen atom in the pyrazine, resulting in a dramatic anodic shift of ca. 500 mV of the first reduction potential compared to those of 1 and 2. The CVs and the DFT calculations demonstrate that the LUMOs of 1 and 2 reside mainly on the CN ligands whereas in 3 it is localized on the pyrazine (Tables S8–S10 and Fig. S15, ESI). In 1 and 2, the absorption band for the HOMO–LUMO is predominantly ppy π–π* in nature while for 3 it is mixed CT, i.e., the LUMO is different in both cases.

The steady-state emission spectra of 1–3 were recorded in degassed MeCN at 298 K and are shown in Fig. 3. The photophysical data are summarized in Table 1. The emission spectra for 1 and 3 are broad and featureless, indicative of mixed 3CT emission while the spectrum of 2 is structured, pointing to significant 3LC-based emission. TD-DFT calculations (Fig. S16–S18, ESI) corroborate these assignments. The CT emission in 1 is the result of mixed LLCT and MLCT that is mostly LLCT in nature and involves the pyridine moieties of the CN ligands while the CT emission of 3 is also mixed with almost equal LLCT and MLCT contributions that involve the pyrazine of the gpz ligand. The emission maximum of 3 is at 640 nm, which is significantly red-shifted as compared to those of 1 and 2. With the presence of the dFMeppy ligand, the emission maximum in 2 is expectedly blue-shifted to 470 nm. Consistent with the absorption and electrochemical data, the emission maxima for 1 and 2 are hypsochromically shifted as compared to those of C1 (λmax = 602 nm) and C2 (λmax = 527 nm).15 This effect is again due to the strong σ-donating nature of the guanidyl moiety that destabilizes both the HOMO and LUMO, the latter to a greater extent resulting in a larger HOMO–LUMO gap. In the case of 3, the LUMO now resides on the guanidine-based ligand, which is significantly lower in energy due to the electron-deficient pyrazine moiety.


image file: c5cc04069h-f3.tif
Fig. 3 Normalized emission spectra of 1–3 (λexc = 395 nm) recorded in degassed MeCN at 298 K. The first band at 450 nm for compound 3 correspond to a Raman band of MeCN.

The photoluminescence quantum yields, ΦPL, in degassed MeCN for 1 and 2 are ca. 61%. Complex 3, by contrast is very poorly emissive (ΦPL = 0.2%) due to a two-order increase in the non-radiative decay rate constant, knr. The inference is that implicating the pyrazine-based ancillary ligand in the triplet state results in quenched emission. Emission lifetimes for 1 and 2 are 2.1 and 2.6 μs, respectively, and are significantly longer than that of C1 (τε = 0.275 μs)15 while the τε of 3 is only 20 ns. The conformational flexibility present in the saturated backbone of the guanidyl cycle coupled with a triplet state involving the pyrazine moiety, may be responsible for the short observed lifetime in 3. Indeed, very efficient vibrational deactivation was previously noted for Ru(II) complexes of guanidine-based ligands.6

In summary, a new class of blue-green emissive iridium(III) cationic complexes with partially saturated guanidyl-containing ancillary ligands is reported. The strong electron-donating character of the guanidyl cycle confers a very large blue shift in the emission compared to benchmark complex C1 while maintaining high photoluminescence quantum yields and microsecond emission lifetimes. Incorporation of a pyrazine unit in 3 results in near complete quenching of the luminescence with a concomitant red-shift of its emission wavelength. The overall structural, electrochemical and photophysical properties of 1 and 2 are encouraging and current efforts are underway to investigate these complexes as emissive materials in solid-state lighting applications.

The authors are grateful to the Natural Sciences and Engineering Research Council (NSERC) of Canada, le Fonds québécois de la recherche sur la nature et les technologies (FRQNT), the Centre for Self Assembled Chemical Structures (CSACS), the Centre in Green Chemistry and Catalysis (CCVC), and the Université de Montréal (UdeM) for financial support. UdeM XRD, NMR, EA, and MS services and personnel, as well as Compute Canada, are also thanked. EZ-C acknowledges the University of St Andrews for financial support.

Notes and references

  1. (a) R. D. Costa, E. Ortí, H. J. Bolink, F. Monti, G. Accorsi and N. Armaroli, Angew. Chem., Int. Ed., 2012, 51, 8178 CrossRef CAS PubMed; (b) T. Hu, L. He, L. Duan and Y. Qiu, J. Mater. Chem., 2012, 22, 4206 RSC; (c) G. E. Schneider, A. Pertegás, E. C. Constable, C. E. Housecroft, N. Hostettler, C. D. Morris, J. A. Zampese, H. J. Bolink, J. M. Junquera-Hernández, E. Ortí and M. Sessolo, J. Mater. Chem. C, 2014, 2, 7047 RSC; (d) A. B. Bünzli, H. J. Bolink, E. C. Constable, C. E. Housecroft, J. M. Junquera-Hernández, N. Neuburger, E. Ortí, A. Pertegás, J. J. Serrano-Pérez, D. Tordera and J. A. Zampese, Dalton Trans., 2014, 43, 738 RSC; (e) K. Hasan, L. Donato, Y. Shen, J. D. Slinker and E. Zysman-Colman, Dalton Trans., 2014, 43, 13672 RSC.
  2. (a) K. Hasan and E. Zysman-Colman, Inorg. Chem., 2012, 51, 12560–12564 CrossRef CAS PubMed; (b) Y. Shinpuku, F. Inui, M. Nakai and Y. Nakabayashi, J. Photochem. Photobiol., A, 2011, 22, 203 CrossRef PubMed.
  3. For recent review and examples see; (a) K. K.-W. Lo and S. P.-Y. Li, RSC Adv., 2014, 4, 10560 RSC; (b) K. K.-W. Lo and K. Y. Zhang, RSC Adv., 2012, 2, 12069 RSC; (c) F. Lu and T. Nabeshima, Dalton Trans., 2014, 43, 9529 RSC; (d) Y. You, Curr. Opin. Chem. Biol., 2013, 17, 699 CrossRef CAS PubMed; (e) Y. You, S. Lee, T. Kim, K. Ohkubo, W.-S. Chae, S. Fukuzumi, G.-J. Jhon, W. Nam and S. J. Lippard, J. Am. Chem. Soc., 2011, 133, 18328 CrossRef CAS PubMed.
  4. (a) K. Mori, J. Aoyama, M. Kawashimaa and H. Yamashita, Dalton Trans., 2014, 43, 10541 RSC; (b) D. R. Whang, K. Sakai and S. Y. Park, Angew. Chem., Int. Ed., 2013, 52, 11612 CrossRef CAS PubMed; (c) S. Hansen, M.-M. Pohl, M. Klahn, A. Spannenberg and T. Beweries, ChemSusChem, 2013, 6, 92 CrossRef CAS PubMed; (d) B. F. Disalle and S. Bernhard, J. Am. Chem. Soc., 2011, 133, 11819 CrossRef CAS PubMed; (e) F. Gärtner, D. Cozzula, S. Losse, A. Boddien, G. Anilkumar, H. Junge, T. Schulz, N. Marquet, A. Spannenberg, S. Gladiali and M. Beller, Chem. – Eur. J., 2011, 17, 6998 CrossRef PubMed; (f) L. L. Tinker and S. Bernhard, Inorg. Chem., 2009, 48, 10507 CrossRef CAS PubMed.
  5. (a) K. P. S. Zanoni, B. K. Kariyazaki, A. Ito, M. K. Brennaman, T. J. Meyer and N. Y. Murakami Iha, Inorg. Chem., 2014, 53, 4089 CrossRef CAS PubMed; (b) L. He, J. Qiao, L. Duan, G. Dong, D. Zhang, L. Wang and Y. Qiu, Adv. Funct. Mater., 2009, 19, 2950 CrossRef CAS PubMed; (c) G. J. Barbante, E. H. Doeven, E. Kerr, T. U. Connell, P. S. Donnelly, J. M. White, T. Lópes, S. Laird, D. J. D. Wilson, P. J. Barnard, C. F. Hogan and P. S. Francis, Chem. – Eur. J., 2014, 20, 3322 CrossRef CAS PubMed; (d) S. Stagni, S. Colella, A. Palazzi, G. Valenti, S. Zacchini, F. Paolucci, M. Marcaccio, R. Q. Albuquerque and L. De Cola, Inorg. Chem., 2008, 47, 10509 CrossRef CAS PubMed; (e) L. He, L. Duan, J. Qiao, D. Zhang, L. Wang and Y. Qiu, Chem. Commun., 2011, 47, 6467 RSC; (f) S. Ladouceur and E. Zysman-Colman, Eur. J. Inorg. Chem., 2013, 2985 CrossRef CAS PubMed.
  6. (a) A. K. Pal, S. Nag, J. G. Ferreina, V. Brochery, G. L. Ganga, A. Santora, S. Serroni, S. Campagna and G. S. Hanan, Inorg. Chem., 2014, 53, 1679 CrossRef CAS PubMed; (b) A. K. Pal, P. D. Ducharme and G. S. Hanan, Chem. Commun., 2014, 50, 3303 RSC; (c) A. K. Pal and G. S. Hanan, Dalton Trans., 2014, 43, 6567 RSC; (d) A. K. Pal, N. Zaccheroni, S. Campagna and G. S. Hanan, Chem. Commun., 2014, 50, 6846 RSC; (e) A. K. Pal, S. Serroni, N. Zaccheroni, S. Campagna and G. S. Hanan, Chem. Sci., 2014, 5, 4800 RSC; (f) A. K. Pal and G. S. Hanan, Chem. Soc. Rev., 2014, 43, 6184 RSC; (g) S. Nag, J. G. Ferreira, L. Chenneberg, P. D. Ducharme, G. S. Hanan, G. L. Ganga, S. Serroni and S. Campagna, Inorg. Chem., 2011, 50, 7 CrossRef CAS PubMed.
  7. (a) S. H. Oakley, M. P. Coles and P. B. Hitchcock, Inorg. Chem., 2004, 43, 7564 CrossRef CAS PubMed; (b) M. P. Coles, Chem. Commun., 2009, 3659 RSC; (c) M. S. Khalaf, S. H. Oakley, M. P. Coles and P. B. Hitchcock, Dalton Trans., 2010, 39, 1635 RSC.
  8. (a) B. De Groot, G. S. Hanan and S. J. Loeb, Inorg. Chem., 1991, 30, 4644 CrossRef CAS; (b) G. R. Giesbrecht, G. S. Hanan, J. E. Kickham and S. J. Loeb, Inorg. Chem., 1992, 31, 3286 CrossRef CAS.
  9. R. D. Costa, E. Ortí, H. J. Bolink, S. Graber, S. Schffner, M. Neuburger, C. E. Housecroft and E. C. Constable, Adv. Funct. Mater., 2009, 19, 3456 CrossRef CAS PubMed.
  10. S. Ladouceur, D. Fortin and E. Zysman-Colman, Inorg. Chem., 2010, 49, 5625 CrossRef CAS PubMed and references cited therein.
  11. For overlay of experimental absorption spectra of the complexes in acetonitrile with their predicted transitions and oscillator strength, see Fig. S14–S16, ESI.
  12. V. V. Pavlishchuk and A. W. Addison, Inorg. Chim. Acta, 2000, 298, 97 CrossRef CAS.
  13. (a) L. Donato, P. Abel and E. Zysman-Colman, Dalton Trans., 2013, 42, 8402 RSC; (b) J. H. van Diemen, J. G. Haasnoot, R. Hage, E. Müller and J. Reedijk, Inorg. Chim. Acta, 1991, 181, 245 CrossRef CAS.
  14. (a) E. Orselli, R. Q. Albuquerque, P. M. Fransen, R. Frohlich, H. M. Janssen and L. De Cola, J. Mater. Chem., 2008, 18, 4579 RSC; (b) J. M. Fernandez-Hernandez, S. Ladouceur, Y. Shen, A. Iordache, X. Wang, L. Donato, S. Gallagher-Duval, M. de Anda Villa, J. D. Slinker, L. De Cola and E. Zysman-Colman, J. Mater. Chem. C, 2013, 1, 7440 RSC.
  15. S. Ladouceur, D. Fortin and E. Zysman-Colman, Inorg. Chem., 2011, 50, 11514 CrossRef CAS PubMed.
  16. W. H. Melhuish, J. Phys. Chem., 1961, 65, 229 CrossRef CAS.

Footnote

Electronic supplementary information (ESI) available. CCDC 1015124. For ESI and crystallographic data in CIF or other electronic format see DOI: 10.1039/c5cc04069h

This journal is © The Royal Society of Chemistry 2015
Click here to see how this site uses Cookies. View our privacy policy here.